Skip to main content

Pharming Group held an analyst call on the 13th of May at 13:30CET/07:30EST 

The slides for this call are available here 

As previously experienced, the progression of the COVID-19 pandemic has resulted in quarterly fluctuations in revenue. Results in Q1 2021 were negatively affected in the US by a severe COVID-19 surge at the end of 2020 and into 2021

- Sijmen de Vries - CEO
Cookies: This website uses cookies Check the cookies page for more information Accept Decline